Apr 19, 2003

Effect of endosinusal treatment on cellular markers in mild and moderate asthmatics

Acta Oto-laryngologica
L KalogjeraT Baudoin

Abstract

To determine the efficacy of topical endosinusal treatment in terms of reduction in activation of inflammatory cells and asthma/rhinosinusitis symptoms in patients with asthma and chronic rhinosinusitis (CRS). Eighteen mild-to-moderate asthmatics with CRS were subjected to antral sinoscopy and endosinusal treatment with 2 mg of dexamethasone and 40 mg of gentamicin per maxillary sinus for 7 days. Sinus lavage and serum samples were taken before and after the treatment and bacteriological swabs from the sinuses were taken at the time of inclusion in the study. Subjective scores for CRS symptoms and forced expiratory volume in 1 s (FEV1) were tested at inclusion and after 30 days. Levels of eosinophil cationic protein (ECP), tryptase and myeloperoxidase (MPO) were analyzed in serum and sinus fluid before and after the treatment. ECP and tryptase levels were significantly reduced in both serum and sinus fluid, but serum MPO did not show significant changes after the treatment. MPO in sinus lavage was reduced only in moderate asthmatics. Subjective scores for CRS and FEV1 were significantly improved for the whole group. ECP, usually used as a parameter for asthma staging, was mostly affected at the systemic level, whilst tryptase w...Continue Reading

  • References11
  • Citations5

Citations

Mentioned in this Paper

Eosinophil
Entire Maxillary Sinus
Eosinophil cationic protein
Rhinosinusitis
Chronic Sinusitis
Mast Cell
Tryptase Measurement
Gentamicins
Inflammation Mediators
Gentacycol

About this Paper

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

The Annals of Otology, Rhinology, and Laryngology
Neil Bhattacharyya, Lynn J Kepnes
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Warren LenneyJohn M Kovarik
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine
Beth L Laube
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine
M DurandC Martin
© 2020 Meta ULC. All rights reserved